Cognex Corporation (NASDAQ:CGNX – Get Free Report) VP Laura Ann Macdonald sold 41,600 shares of Cognex stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the sale, the vice president directly owned 5,258 shares in the company, valued at $344,714.48. This trade represents a 88.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Laura Ann Macdonald also recently made the following trade(s):
- On Monday, May 11th, Laura Ann Macdonald sold 98,122 shares of Cognex stock. The stock was sold at an average price of $66.80, for a total transaction of $6,554,549.60.
- On Thursday, February 12th, Laura Ann Macdonald sold 14,881 shares of Cognex stock. The stock was sold at an average price of $57.16, for a total transaction of $850,597.96.
Cognex Price Performance
Cognex stock opened at $65.68 on Wednesday. Cognex Corporation has a 12-month low of $29.00 and a 12-month high of $71.90. The company has a market capitalization of $10.93 billion, a price-to-earnings ratio of 78.19 and a beta of 1.48. The firm’s fifty day moving average price is $53.30 and its 200 day moving average price is $45.60.
Cognex Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st will be given a $0.085 dividend. The ex-dividend date of this dividend is Thursday, May 21st. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s payout ratio is presently 40.48%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on CGNX shares. Wall Street Zen raised shares of Cognex from a “hold” rating to a “buy” rating in a research report on Saturday. Barclays reissued an “overweight” rating and issued a $75.00 target price (up from $64.00) on shares of Cognex in a research report on Monday. Robert W. Baird set a $72.00 target price on shares of Cognex in a research report on Friday. Stephens boosted their target price on shares of Cognex from $65.00 to $75.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $75.00 target price on shares of Cognex in a research report on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cognex has an average rating of “Moderate Buy” and a consensus price target of $68.86.
Get Our Latest Research Report on Cognex
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Cognex by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 18,598,728 shares of the scientific and technical instruments company’s stock valued at $842,522,000 after purchasing an additional 374,999 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in Cognex by 173,138.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company’s stock valued at $376,979,000 after purchasing an additional 10,471,400 shares during the period. Nordea Investment Management AB boosted its stake in Cognex by 0.9% during the 4th quarter. Nordea Investment Management AB now owns 8,101,583 shares of the scientific and technical instruments company’s stock valued at $292,224,000 after purchasing an additional 76,212 shares during the period. Pictet Asset Management Holding SA boosted its stake in Cognex by 27.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock valued at $252,360,000 after purchasing an additional 1,529,010 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in Cognex by 31.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company’s stock valued at $191,231,000 after purchasing an additional 1,258,629 shares during the period. 88.12% of the stock is owned by institutional investors and hedge funds.
Cognex Company Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
See Also
- Five stocks we like better than Cognex
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
